SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway

被引:8
作者
Xia, Kezhou [1 ]
Huang, Xinghan [1 ]
Zhao, Yingchun [1 ]
Yang, Isabelle [1 ]
Guo, Weichun [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Orthopaed, 238 Jiefang Rd, Wuhan 430060, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2024年 / 39卷
关键词
Osteosarcoma; SERPINH1; Pi3K-Akt signaling pathway; Proliferation; Invasion; CANCER; HSP47; EXPRESSION; PI3K/AKT; METASTASIS; INVASION; PROTEIN; GROWTH; LUNG;
D O I
10.1016/j.tranon.2023.101802
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Serpin Family H Member 1 (SERPINH1) may be involved in the regulation of occurrence and development of tumors. However, the role and mechanism of SERPINH1 in osteosarcoma remain poorly un-derstood. The aim of this study is to investigate the expression and role of SRPINH1 in osteosarcoma and to elucidate its underlying mechanisms.Methods: First, we examined the expression of SERPINH1 in osteosarcoma and analyzed publicly available datasets to investigate whether SERPINH1 expression was associated with the prognosis of osteosarcoma. Then we constructed SERPINH1 overexpression and knockdown systems in osteosarcoma cells, and examined the proliferation, migration and invasion ability of osteosarcoma cells after SERPINH1 expression changes using CCK-8 assay, wound healing assay and transwell invasion assay. In addition, we constructed a subcutaneous xenograft tumor model to study the function of SERPINH1 in vivo. We also examined the downstream pathways of SERPINH1 by functional analysis and performed subsequent validation.Results: SERPINH1 was upregulated and associated with poor survival in patients with osteosarcoma. SERPINH1 promoted the proliferation, migration and invasion of osteosarcoma cells and promotes the growth of osteo-sarcoma in vivo by activating the PI3K-Akt signaling pathway.Conclusion: SERPINH1 partakes in the biological process of osteosarcoma as a tumor promotor and may be an emerging biomarker in osteosarcoma.
引用
收藏
页数:10
相关论文
共 30 条
  • [1] High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach
    Araki, K.
    Mikami, T.
    Yoshida, T.
    Kikuchi, M.
    Sato, Y.
    Oh-ishi, M.
    Kodera, Y.
    Maeda, T.
    Okayasu, I.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (03) : 492 - 497
  • [2] Analysis of cancer-related IncRNAs using gene ontology and KEGG pathways
    Chen, Lei
    Zhang, Yu-Hang
    Lu, Guohui
    Huang, Tao
    Cai, Yu-Dong
    [J]. ARTIFICIAL INTELLIGENCE IN MEDICINE, 2017, 76 : 27 - 36
  • [3] Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma
    Chui, Michael Herman
    Kandel, Rita A.
    Wong, Marcus
    Griffin, Anthony M.
    Bell, Robert S.
    Blackstein, Martin E.
    Wunder, Jay S.
    Dickson, Brendan C.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (11) : 1231 - 1242
  • [4] The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
    Dong, Peixin
    Konno, Yosuke
    Watari, Hidemichi
    Hosaka, Masayoshi
    Noguchi, Masayuki
    Sakuragi, Noriaki
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [5] Mechanisms of hepatic fibrogenesis
    Friedman, Scott L.
    [J]. GASTROENTEROLOGY, 2008, 134 (06) : 1655 - 1669
  • [6] PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway
    Gao, Xue
    Qin, Tao
    Mao, Jun
    Zhang, Jun
    Fan, Shujun
    Lu, Ying
    Sun, Zhigang
    Zhang, Qingqing
    Song, Bo
    Li, Lianhong
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [7] ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
    Li, Hongyu
    Shen, Xin
    Ma, Mengjun
    Liu, Wenzhou
    Yang, Wen
    Wang, Peng
    Cai, Zhaopeng
    Mi, Rujia
    Lu, Yixuan
    Zhuang, Jiahao
    Jiang, Yuhang
    Song, Yihui
    Wu, Yanfeng
    Shen, Huiyong
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [8] Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
    Lussier, Danielle M.
    Johnson, John L.
    Hingorani, Pooja
    Blattman, Joseph N.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [9] Maitra A, 2002, AM J CLIN PATHOL, V118, P52
  • [10] A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma
    Mirabello, Lisa
    Yu, Kai
    Berndt, Sonja I.
    Burdett, Laurie
    Wang, Zhaoming
    Chowdhury, Salma
    Teshome, Kedest
    Uzoka, Arinze
    Hutchinson, Amy
    Grotmol, Tom
    Douglass, Chester
    Hayes, Richard B.
    Hoover, Robert N.
    Savage, Sharon A.
    [J]. BMC CANCER, 2011, 11